Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Jeff Jones's Stock Ratings
Oppenheimer Analyst
Jeff Jones is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-0.01%
Smart Score
Overall Average Return Percentile
34th
Number of Ratings
121
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | 40.06% | $67 → $120 | Maintains | Outperform | Get Alert | |
| 11/14/2025 | PTHS | Buy Now | Pelthos Therapeutics | — | — | $50 → $57 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/27/2025 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 64.51% | $9 → $14 | Maintains | Outperform | Get Alert | |
| 10/01/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -26.47% | $53 → $63 | Maintains | Outperform | Get Alert | |
| 09/02/2025 | PTHS | Buy Now | Pelthos Therapeutics | — | — | → $50 | Initiates | → Outperform | Get Alert | |
| 08/27/2025 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 1113.59% | $10 → $25 | Maintains | Outperform | Get Alert | |
| 08/06/2025 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 461.44% | $56 → $53 | Maintains | Outperform | Get Alert | |
| 06/27/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -38.14% | $56 → $53 | Maintains | Outperform | Get Alert | |
| 06/24/2025 | AVBP | Buy Now | ArriVent BioPharma | $23.58 | 86.6% | $39 → $44 | Maintains | Outperform | Get Alert | |
| 05/29/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $20 → $15 | Maintains | Outperform | Get Alert | |
| 05/16/2025 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 385.44% | $11 → $10 | Maintains | Outperform | Get Alert | |
| 05/15/2025 | ALMS | Buy Now | Alumis | $11.53 | 116.83% | $26 → $25 | Maintains | Outperform | Get Alert | |
| 05/14/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $21 → $20 | Maintains | Outperform | Get Alert | |
| 05/09/2025 | ZURA | Buy Now | Zura Bio | $4.07 | 317.69% | $19 → $17 | Maintains | Outperform | Get Alert | |
| 05/09/2025 | CRVS | Buy Now | Corvus Pharma | $8.26 | 105.81% | $15 → $17 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/08/2025 | IMCR | Buy Now | Immunocore Holdings | $36.02 | 138.76% | $85 → $86 | Maintains | Outperform | Get Alert | |
| 05/07/2025 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 493.22% | $60 → $56 | Maintains | Outperform | Get Alert | |
| 03/26/2025 | ZURA | Buy Now | Zura Bio | $4.07 | 366.83% | $20 → $19 | Maintains | Outperform | Get Alert | |
| 03/26/2025 | CRVS | Buy Now | Corvus Pharma | $8.26 | 81.6% | $14 → $15 | Maintains | Outperform | Get Alert | |
| 03/05/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $23 → $21 | Maintains | Outperform | Get Alert | |
| 02/10/2025 | ALMS | Buy Now | Alumis | $11.53 | 125.5% | $32 → $26 | Maintains | Outperform | Get Alert | |
| 01/30/2025 | ALMS | Buy Now | Alumis | $11.53 | 177.54% | → $32 | Initiates | → Outperform | Get Alert | |
| 01/24/2025 | EVH | Buy Now | Evolent Health | $4.01 | 348.88% | $28 → $18 | Maintains | Outperform | Get Alert | |
| 12/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $3.20 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 11/22/2024 | CATX | Buy Now | Perspective Therapeutics | $2.55 | 527.33% | $22 → $16 | Maintains | Outperform | Get Alert | |
| 11/19/2024 | CLRB | Buy Now | Cellectar Biosciences | $3.20 | 275% | $14 → $12 | Maintains | Outperform | Get Alert | |
| 11/18/2024 | EVH | Buy Now | Evolent Health | $4.01 | 598.25% | $34 → $28 | Maintains | Outperform | Get Alert | |
| 11/18/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $23 | Initiates | → Outperform | Get Alert | |
| 11/15/2024 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 433.98% | $13 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/13/2024 | CRVS | Buy Now | Corvus Pharma | $8.26 | 69.49% | $8 → $14 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/08/2024 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 5.76% | $10 → $9 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/08/2024 | EVH | Buy Now | Evolent Health | $4.01 | 747.88% | $45 → $34 | Maintains | Outperform | Get Alert | |
| 10/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $3.20 | 337.5% | $14 → $14 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/11/2024 | CATX | Buy Now | Perspective Therapeutics | $2.55 | 762.58% | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -34.64% | $52 → $56 | Maintains | Outperform | Get Alert | |
| 09/10/2024 | AVBP | Buy Now | ArriVent BioPharma | $23.58 | 65.39% | $35 → $39 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/15/2024 | AVBP | Buy Now | ArriVent BioPharma | $23.58 | 48.43% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/13/2024 | CATX | Buy Now | Perspective Therapeutics | $2.55 | 566.54% | $19 → $17 | Maintains | Outperform | Get Alert | |
| 08/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $36.02 | 147.08% | $87 → $89 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/08/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3443.31% | $48 → $45 | Maintains | Outperform | Get Alert | |
| 08/07/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 832.2% | $80 → $88 | Maintains | Outperform | Get Alert | |
| 07/10/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -39.31% | $52 → $52 | Maintains | Outperform | Get Alert | |
| 07/10/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 747.46% | $80 → $80 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/18/2024 | CATX | Buy Now | Perspective Therapeutics | $2.55 | — | — | Reiterates | Outperform → Outperform | Get Alert | |
| 06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $17.00 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 06/06/2024 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 17.51% | $12 → $10 | Maintains | Outperform | Get Alert | |
| 06/03/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 747.46% | $60 → $80 | Maintains | Outperform | Get Alert | |
| 05/10/2024 | ZURA | Buy Now | Zura Bio | $4.07 | 415.97% | $16 → $21 | Maintains | Outperform | Get Alert | |
| 05/09/2024 | MCRB | Buy Now | Seres Therapeutics | $17.00 | -76.47% | $5 → $4 | Maintains | Outperform | Get Alert | |
| 05/08/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 535.59% | $58 → $60 | Maintains | Outperform | Get Alert | |
| 05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3679.53% | $47 → $48 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/07/2024 | CRVS | Buy Now | Corvus Pharma | $8.26 | -3.15% | $7 → $8 | Maintains | Outperform | Get Alert | |
| 05/06/2024 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 191.26% | → $6 | Upgrade | Perform → Outperform | Get Alert | |
| 05/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -39.31% | $53 → $52 | Maintains | Outperform | Get Alert | |
| 04/22/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -38.14% | → $53 | Initiates | → Outperform | Get Alert | |
| 04/01/2024 | ZURA | Buy Now | Zura Bio | $4.07 | 293.12% | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/01/2024 | CATX | Buy Now | Perspective Therapeutics | $2.55 | -41.19% | $1.2 → $1.5 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/01/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | — | — | Reiterates | Perform → Perform | Get Alert | |
| 03/28/2024 | CLRB | Buy Now | Cellectar Biosciences | $3.20 | 275% | $11 → $12 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/20/2024 | CRVS | Buy Now | Corvus Pharma | $8.26 | -15.25% | $8 → $7 | Maintains | Outperform | Get Alert | |
| 03/19/2024 | CATX | Buy Now | Perspective Therapeutics | $2.55 | -52.95% | $1.2 → $1.2 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/13/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 514.41% | $51 → $58 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 41.01% | → $12 | Upgrade | Perform → Outperform | Get Alert | |
| 03/08/2024 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | — | — | Maintains | Perform | Get Alert | |
| 03/06/2024 | MCRB | Buy Now | Seres Therapeutics | $17.00 | -70.59% | $9 → $5 | Maintains | Outperform | Get Alert | |
| 03/01/2024 | EVH | Buy Now | Evolent Health | $4.01 | 1022.19% | → $45 | Initiates | → Outperform | Get Alert | |
| 02/29/2024 | PDCO | Buy Now | Patterson Cos | — | — | $32 → $30 | Maintains | Neutral | Get Alert | |
| 02/21/2024 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | — | — | Reiterates | → Perform | Get Alert | |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 01/29/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 440.25% | $20 → $51 | Maintains | Outperform | Get Alert | |
| 01/16/2024 | MCRB | Buy Now | Seres Therapeutics | $17.00 | -47.06% | $10 → $9 | Maintains | Outperform | Get Alert | |
| 01/05/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $13 → $15 | Maintains | Outperform | Get Alert | |
| 12/27/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/30/2023 | PDCO | Buy Now | Patterson Cos | — | — | $35 → $32 | Maintains | Neutral | Get Alert | |
| 09/29/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $13 | Initiates | → Outperform | Get Alert | |
| 08/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3994.49% | $51 → $52 | Maintains | Outperform | Get Alert | |
| 08/09/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 133.05% | → $22 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/05/2023 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 628.55% | $62 → $62 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/22/2023 | PDCO | Buy Now | Patterson Cos | — | — | $31 → $35 | Maintains | Neutral | Get Alert | |
| 06/07/2023 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 06/01/2023 | NOVN | Buy Now | Novan | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 05/25/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | — | — | → $8 | Maintains | Outperform | Get Alert | |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | $6.65 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 05/19/2023 | CATX | Buy Now | Perspective Therapeutics | $2.55 | -52.95% | $1 → $1.2 | Maintains | Outperform | Get Alert | |
| 05/16/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | → $13 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/16/2023 | NOVN | Buy Now | Novan | — | — | $9 → $8 | Maintains | Outperform | Get Alert | |
| 05/11/2023 | PMVP | Buy Now | PMV Pharma | $1.20 | 1150.1% | → $15 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3915.75% | $44 → $51 | Maintains | Outperform | Get Alert | |
| 05/10/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 133.05% | → $22 | Upgrade | Perform → Outperform | Get Alert | |
| 04/18/2023 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 239.81% | $12 → $7 | Maintains | Outperform | Get Alert | |
| 03/30/2023 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | 2081.82% | $20 → $24 | Maintains | Outperform | Get Alert | |
| 03/24/2023 | MBRX | Buy Now | Moleculin Biotech | $4.44 | 12.61% | → $5 | Reiterates | → Outperform | Get Alert | |
| 03/24/2023 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 628.55% | $65 → $62 | Maintains | Outperform | Get Alert | |
| 03/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3364.57% | $43 → $44 | Maintains | Outperform | Get Alert | |
| 03/07/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | — | — | $10 → $8 | Maintains | Outperform | Get Alert | |
| 03/02/2023 | PMVP | Buy Now | PMV Pharma | $1.20 | 1150.1% | $28 → $15 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | $125 → $150 | Maintains | Outperform | Get Alert | |
| 01/27/2023 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 605.05% | $55 → $60 | Maintains | Outperform | Get Alert | |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $61 → $125 | Maintains | Outperform | Get Alert | |
| 11/17/2022 | EVAX | Buy Now | Evaxion Biotech | $5.68 | 93.66% | $16 → $11 | Maintains | Outperform | Get Alert | |
| 10/11/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | → $20 | Initiates | → Outperform | Get Alert | |
| 10/04/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $50 → $65 | Maintains | Outperform | Get Alert | |
| 09/12/2022 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 663.81% | $40 → $65 | Maintains | Outperform | Get Alert | |
| 08/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 370.04% | $30 → $40 | Maintains | Outperform | Get Alert | |
| 07/19/2022 | NOVN | Buy Now | Novan | — | — | → $12 | Initiates | → Outperform | Get Alert | |
| 07/18/2022 | CLRB | Buy Now | Cellectar Biosciences | $3.20 | 71.87% | → $5.5 | Assumes | → Outperform | Get Alert | |
| 07/18/2022 | CYCC | Buy Now | Cyclacel Pharmaceuticals | — | — | → $17 | Assumes | → Outperform | Get Alert | |
| 07/18/2022 | EVAX | Buy Now | Evaxion Biotech | $5.68 | 181.69% | → $16 | Assumes | → Outperform | Get Alert | |
| 07/18/2022 | MBRX | Buy Now | Moleculin Biotech | $4.44 | 215.32% | → $14 | Assumes | → Outperform | Get Alert | |
| 07/18/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | → $5.5 | Assumes | → Outperform | Get Alert | |
| 06/09/2022 | PMVP | Buy Now | PMV Pharma | $1.20 | 2650.23% | $30 → $33 | Maintains | Outperform | Get Alert | |
| 04/01/2022 | RAIN | Buy Now | Rain Oncology | $6.65 | 125.66% | → $15 | Initiates | → Outperform | Get Alert | |
| 03/10/2022 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 870.87% | $30 → $20 | Maintains | Outperform | Get Alert | |
| 03/02/2022 | PMVP | Buy Now | PMV Pharma | $1.20 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 02/01/2022 | VTYX | Buy Now | Ventyx Biosciences | $8.51 | 252.53% | → $30 | Initiates | → Outperform | Get Alert | |
| 12/10/2021 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3049.61% | → $40 | Initiates | → Outperform | Get Alert | |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | $35 → $50 | Upgrade | Perform → Outperform | Get Alert | |
| 11/15/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 10/05/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | → $35 | Initiates | → Outperform | Get Alert | |
| 08/19/2021 | PMVP | Buy Now | PMV Pharma | $1.20 | — | — | Initiates | → Perform | Get Alert | |
| 05/07/2021 | CMMB | Buy Now | Chemomab Therapeutics | $2.06 | 1938.83% | → $42 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved